PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $87,000 | -91.9% | 13,883 | -95.9% | 0.00% | -100.0% |
| Q1 2020 | $1,071,000 | +565.2% | 339,869 | +2051.1% | 0.01% | +1200.0% |
| Q2 2018 | $161,000 | -8.5% | 15,800 | +17.0% | 0.00% | 0.0% |
| Q1 2018 | $176,000 | -97.9% | 13,500 | -96.1% | 0.00% | -97.1% |
| Q2 2017 | $8,435,000 | +9.9% | 350,000 | -12.2% | 0.04% | -2.8% |
| Q1 2017 | $7,678,000 | +99.2% | 398,850 | +59.3% | 0.04% | +71.4% |
| Q4 2016 | $3,855,000 | – | 250,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |